<?xml version="1.0" encoding="UTF-8"?>
<p>The utility of combined administration of IVIgG (intravenous Immunoglobulin G) and low molecular weight heparin (LMWH) anticoagulant therapy was suggested since infection, inflammation, and other factors may lead to disseminated intravascular coagulation [
 <xref rid="B14-ijms-21-05145" ref-type="bibr">14</xref>].
</p>
